Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Haisma

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|May 1, 1976
[Studies on the hyperventilation syndrome. I. Pattern of symptoms]J M Buitenhuis, J Droogleever Fortuyn, H J Haisma, et al.
Nuclear Medicine and Biology|May 1, 1996
A facile method for the labeling of proteins with zirconium isotopesW E Meijs, H J Haisma, R Van der Schors, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Tumour localisation with 131I-labelled human IgM monoclonal antibody 16.88 in advanced colorectal cancer patientsE Boven, H J Haisma, H Bril, et al.
Journal of the National Cancer Institute|December 18, 1991
Human IgM monoclonal antibody 16.88: pharmacokinetics and immunogenicity in colorectal cancer patientsH J Haisma, H M Pinedo, M A Kessel, et al.
European Journal of Nuclear Medicine|March 1, 1994
Comparison of non-invasive approaches to red marrow dosimetry for radiolabelled monoclonal antibodiesM A Plaizier, J C Roos, G J Teule, et al.
Cancer Gene Therapy|August 13, 2005
The carcinoma-specific epithelial glycoprotein-2 promoter controls efficient and selective gene expression in an adenoviral contextW M Gommans, S J van Eert, P M J McLaughlin, et al.
British Journal of Cancer|March 5, 2002
A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrugM de Graaf, E Boven, D Oosterhoff, et al.
Journal of Immunological Methods|March 22, 2000
A rapid and versatile method for harnessing scFv antibody fragments with various biological effector functionsW Helfrich, H J Haisma, V Magdolen, et al.
Bioorganic & Medicinal Chemistry|September 11, 1999
Novel anthracycline-spacer-beta-glucuronide,-beta-glucoside, and -beta-galactoside prodrugs for application in selective chemotherapyR G Leenders, E W Damen, E J Bijsterveld, et al.
British Journal of Cancer|September 19, 2002
Secreted and tumour targeted human carboxylesterase for activation of irinotecanD Oosterhoff, H M Pinedo, I H van der Meulen, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Nederlands Tijdschrift Voor Geneeskunde|May 1, 1976
[Studies on the hyperventilation syndrome. I. Pattern of symptoms]J M Buitenhuis, J Droogleever Fortuyn, H J Haisma, et al.
Nuclear Medicine and Biology|May 1, 1996
A facile method for the labeling of proteins with zirconium isotopesW E Meijs, H J Haisma, R Van der Schors, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Tumour localisation with 131I-labelled human IgM monoclonal antibody 16.88 in advanced colorectal cancer patientsE Boven, H J Haisma, H Bril, et al.
Journal of the National Cancer Institute|December 18, 1991
Human IgM monoclonal antibody 16.88: pharmacokinetics and immunogenicity in colorectal cancer patientsH J Haisma, H M Pinedo, M A Kessel, et al.
European Journal of Nuclear Medicine|March 1, 1994
Comparison of non-invasive approaches to red marrow dosimetry for radiolabelled monoclonal antibodiesM A Plaizier, J C Roos, G J Teule, et al.
Cancer Gene Therapy|August 13, 2005
The carcinoma-specific epithelial glycoprotein-2 promoter controls efficient and selective gene expression in an adenoviral contextW M Gommans, S J van Eert, P M J McLaughlin, et al.
British Journal of Cancer|March 5, 2002
A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrugM de Graaf, E Boven, D Oosterhoff, et al.
Journal of Immunological Methods|March 22, 2000
A rapid and versatile method for harnessing scFv antibody fragments with various biological effector functionsW Helfrich, H J Haisma, V Magdolen, et al.
Bioorganic & Medicinal Chemistry|September 11, 1999
Novel anthracycline-spacer-beta-glucuronide,-beta-glucoside, and -beta-galactoside prodrugs for application in selective chemotherapyR G Leenders, E W Damen, E J Bijsterveld, et al.
British Journal of Cancer|September 19, 2002
Secreted and tumour targeted human carboxylesterase for activation of irinotecanD Oosterhoff, H M Pinedo, I H van der Meulen, et al.
Pageof 8